Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors
This was the stock's fourth consecutive day of losses.
65 Equity Makes Europe Foray With Swiss Pharma Merger
Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s ...
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors
This was the stock's third consecutive day of losses.
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation [...]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today the dosing of the first subject in the ...
Corbus announces first patient dosed in Phase 1 CRB-913 study
Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the ...